CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Protagonist Therapeutics authorizes $300M share repurchase program

Neutral
AI Analysis

Summary

Protagonist Therapeutics authorized a $300 million share repurchase program, reflecting capital allocation decisions by the company.

Importance:2/10
Sentiment:
0.00
share_repurchasecapital_allocation
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on September 8, 2026 8:16 PM

Read Original